Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT07744126
Telisotuzumab Adizutecan, Pembrolizumab, Carboplatin, Cisplatin
AbbVie · Abrir el resumen
Metastatic Nasopharyngeal Carcinoma · Fase 2 · NCT06029270
Biospecimen Collection, Bone Scan, Carboplatin, Cisplatin
National Cancer Institute (NCI) · Abrir el resumen
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Fase 2 · NCT07195734
Biospecimen Collection, Carboplatin, Cemiplimab, Cisplatin
National Cancer Institute (NCI) · Abrir el resumen
Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT06980038
Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Biopsy Procedure, Biospecimen Collection, Cemiplimab
National Cancer Institute (NCI) · Abrir el resumen
Metastatic Salivary Gland Carcinoma · Fase 2 · NCT05408845 · Artículos
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel
NRG Oncology · Abrir el resumen
Head and Neck Squamous Cell Carcinoma (HNSCC) · Fase 2 · NCT06769698
FDC fianlimab+cemiplimab, Cemiplimab, Placebo
Regeneron Pharmaceuticals · Abrir el resumen
Salivary Gland Cancer · Fase 2 · NCT06805617
Ivonescimab
Dana-Farber Cancer Institute · Abrir el resumen
Recurrent Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT04671667
Carboplatin, Cisplatin, Computed Tomography, Intensity-Modulated Radiation Therapy
National Cancer Institute (NCI) · Abrir el resumen
Head and Neck Cancer Squamous Cell Carcinoma · Fase 2 · NCT07773987
Pembrolizumab, Radiotherapy, ENI, Surgery
Medical College of Wisconsin · Abrir el resumen
Head and Neck Cancer · Fase 2 · NCT06239220
PD-L1 t-haNK, Cetuximab, NAI
Dana-Farber Cancer Institute · Abrir el resumen
Squamous Cell Carcinoma of the Head and Neck · Fase 2 · NCT06223568
Docetaxel, Cisplatin, PRGN-2009
National Cancer Institute (NCI) · Abrir el resumen
Squamous Cell Carcinoma of Head and Neck · Fase 2 · NCT05952934
0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
University of Arkansas · Abrir el resumen
Stage II Nasopharyngeal Carcinoma AJCC v8 · Fase 2 · NCT06064097
Biopsy Procedure, Biospecimen Collection, Chest Radiography, Cisplatin
National Cancer Institute (NCI) · Abrir el resumen
Head and Neck Cancer · Fase 2 · NCT07770100
Stereotactic Body Radiation Therapy (SBRT), Pembrolizumab, Nivolumab, Atezolizumab
Mark Bernard · Abrir el resumen
Metastatic Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT07807163
Ficerafusp alfa, Pembrolizumab (KEYTRUDA®)
Bicara Therapeutics · Abrir el resumen
Sinonasal Squamous Cell Carcinoma · Fase 2 · NCT07281417
Biopsy Procedure, Biospecimen Collection, Carboplatin, Cemiplimab
National Cancer Institute (NCI) · Abrir el resumen
Adenoid Cystic Carcinoma · Fase 2 · NCT07162480
P-Sam
M.D. Anderson Cancer Center · Abrir el resumen
Stage II Squamous Cell Carcinoma of the Head and Neck · Fase 2 · NCT06161545
PD-L1 t-haNK cells, pembrolizumab, N-803
National Cancer Institute (NCI) · Abrir el resumen
Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT02734537
Cisplatin, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis
ECOG-ACRIN Cancer Research Group · Abrir el resumen
Laryngeal Squamous Cell Carcinoma · Fase 2 · NCT07392580
Cisplatin, Epinephrine injection, Laryngeal Biopsy, Endoscopic Surgery
University of Miami · Abrir el resumen
Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT05674396
Stereotactic body radiotherapy, Traditional Palliation
M.D. Anderson Cancer Center · Abrir el resumen
Oropharynx Cancer, Stage I · Fase 2 · NCT06254911
Atezolizumab, Transoral Surgery with cervical lymphadenctomy (neck dissection), Computed Tomography, Magnetic Resonance Imaging
Emory University · Abrir el resumen
HPV-Associated Oropharyngeal Squamous Cell Carcinoma · Fase 2 · NCT04900623 · Artículos
NavDx HPV ctDNA Testing, Radiotherapy, Chemotherapy drug
Jonathan Schoenfeld, MD, MPH · Abrir el resumen
Oropharyngeal Cancer · Fase 2 · NCT06445114
Cisplatin
Zachary Zumsteg · Abrir el resumen